바이러스학 검체 채취 시장 : 제품, 검체, 최종사용자별 - 세계 예측(2025-2030년)

The Virology Specimen Collection Market was valued at USD 2.68 billion in 2023, expected to reach USD 3.31 billion in 2024, and is projected to grow at a CAGR of 23.89%, to USD 12.05 billion by 2030.

The market for virology specimen collection is defined by its role in acquiring samples necessary for diagnosing viral infections, which include swabs, blood, urine, and saliva. This market is indispensable due to the critical need for accurate diagnostic tools in both pandemic preparedness and routine virology. Its applications range from clinical diagnostics and drug discovery to epidemiological research, impacting hospitals, diagnostic labs, and research institutes. Driving factors in this sector include the rise in viral outbreaks, heightened awareness about infectious diseases, and advancements in collection methodologies. The use of automation, AI, and improved storage and transport technologies presents significant opportunities. For businesses, tapping into these advancements can yield robust growth; a focus on enhancing sample integrity and integrating digital diagnostic platforms is advised. Despite opportunities, market growth faces challenges such as high costs, stringent regulatory frameworks, and logistical complexities associated with specimen transport and storage. To overcome these, businesses should prioritize cost-effective innovations and partnerships aimed at enhancing supply chain efficiency.

Emerging opportunities lie in developing rapid specimen collection kits that offer convenience and reliability, particularly in resource-constrained settings. Investing in portable diagnostic devices that minimize the need for complex infrastructure can also differentiate market players. The role of telemedicine and digital health solutions in linking specimen collection with comprehensive diagnostic services is another promising avenue for development. Innovation must focus on improving portability, accuracy, and speed of specimen analysis. The market is competitive and rapidly evolving, necessitating constant adaptation to new technologies and customer needs. Companies will benefit from focusing on scalable solutions that can swiftly respond to health emergencies, thus solidifying their role in the global virology landscape. These strategic innovations and collaborations will position businesses to not only meet current demands but also address unforeseen future challenges effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Virology Specimen Collection Market

The Virology Specimen Collection Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of viral diseases and emergence of newer pathogens
  • Growing number of blood donations
  • Government set guidelines to maintain safety of specimen collection
• Market Restraints
  • Concerns regarding inadequate procedures for collection, handling, transport
• Market Opportunities
  • Robust funding from the public and private agencies
  • Development progress in antiviral therapeutics
• Market Challenges
  • High cost of virology specimen collection technologies

Porter's Five Forces: A Strategic Tool for Navigating the Virology Specimen Collection Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Virology Specimen Collection Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Virology Specimen Collection Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Virology Specimen Collection Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Virology Specimen Collection Market

A detailed market share analysis in the Virology Specimen Collection Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Virology Specimen Collection Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Virology Specimen Collection Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Virology Specimen Collection Market

A strategic analysis of the Virology Specimen Collection Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Virology Specimen Collection Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Becton, Dickinson and Company, Element Materials Technology Group Limited, Hardy Diagnostics, HiMedia Laboratories, LLC, LABORATORY ALLIANCE OF CENTRAL NEW YORK, LLC, Laboratory Corporation of America Holdings, Medical Wire & Equipment, Merck KGaA, Omega Bio-tek, Inc., PHARMIWEB.COM LIMITED, Puritan Medical Products, Quidel Corporation, Thermo Fisher Scientific Inc., and Trinity Biotech PLC.

Market Segmentation & Coverage

This research report categorizes the Virology Specimen Collection Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Blood Collection Kits, Specimen Collection Tubes, Swabs, and Viral Transport Media.
• Based on Sample, market is studied across Blood Samples, Cervical Samples, Nasal Samples, Nasopharyngeal Samples, Oral Samples, and Throat Samples.
• Based on End User, market is studied across Diagnostic Centers and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of viral diseases and emergence of newer pathogens
    • 5.1.1.2. Growing number of blood donations
    • 5.1.1.3. Government set guidelines to maintain safety of specimen collection
  • 5.1.2. Restraints
    • 5.1.2.1. Concerns regarding inadequate procedures for collection, handling, transport
  • 5.1.3. Opportunities
    • 5.1.3.1. Robust funding from the public and private agencies
    • 5.1.3.2. Development progress in antiviral therapeutics
  • 5.1.4. Challenges
    • 5.1.4.1. High cost of virology specimen collection technologies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Virology Specimen Collection Market, by Product

• 6.1. Introduction
• 6.2. Blood Collection Kits
• 6.3. Specimen Collection Tubes
• 6.4. Swabs
• 6.5. Viral Transport Media

7. Virology Specimen Collection Market, by Sample

• 7.1. Introduction
• 7.2. Blood Samples
• 7.3. Cervical Samples
• 7.4. Nasal Samples
• 7.5. Nasopharyngeal Samples
• 7.6. Oral Samples
• 7.7. Throat Samples

8. Virology Specimen Collection Market, by End User

• 8.1. Introduction
• 8.2. Diagnostic Centers
• 8.3. Hospitals & Clinics

9. Americas Virology Specimen Collection Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Virology Specimen Collection Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Virology Specimen Collection Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Becton, Dickinson and Company
• 3. Element Materials Technology Group Limited
• 4. Hardy Diagnostics
• 5. HiMedia Laboratories, LLC
• 6. LABORATORY ALLIANCE OF CENTRAL NEW YORK, LLC
• 7. Laboratory Corporation of America Holdings
• 8. Medical Wire & Equipment
• 9. Merck KGaA
• 10. Omega Bio-tek, Inc.
• 11. PHARMIWEB.COM LIMITED
• 12. Puritan Medical Products
• 13. Quidel Corporation
• 14. Thermo Fisher Scientific Inc.
• 15. Trinity Biotech PLC